Steel Exchange India Regulatory Approval

Board Meeting Date

Steel Exchange India Board Meeting Date

Steel Exchange India scheduled a board meeting for 04 Nov 2026 to consider unaudited Q2/H1 results. No financial figures or material decisions are reported in this advance intimation.

Other Announcement

Steel Exchange India Other Announcement

Steel Exchange India Ltd filed its quarterly shareholding pattern. It noted the transmission of 43,31,500 shares due to a promoter's death.

Business Update

Steel Exchange India Business Update

Steel Exchange reported record Re-Bar production, a two-notch credit upgrade, and ₹102 Crore debt reduction in H1 FY27, alongside an NMDC supply MoU.

quarterly Re-Bar production

69617.424 MT

Results Update

Steel Exchange India Results Update

SEIL posted provisional Q2 FY27 revenue of ~₹340 Crore, up 45% YoY, on record Re-Bar output of 69,465 MT. PLI diversification and operational gains mark its turnaround.

Debt & Borrowing

Steel Exchange India Debt & Borrowing: ₹4.29 Cr

Steel Exchange India Limited made a scheduled partial redemption and interest payment totaling ₹4.29 Crore on its Secured Non-Convertible Debentures, complying with Regulation 57(1) of SEBI (LODR).

Value

₹4.29 Cr

Business Update

Steel Exchange India Business Update

Steel Exchange India Limited achieved record production of 25,095.035 MT of re-bars in September 2026. Quarterly production also reached a new high of 69,617.424 MT.

quarterly production

69617.424 MT

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.